Key Details
Price
$5.83Annual ROE
-39.04%Beta
1.85Events Calendar
Next earnings date:
Mar 5, 2025Recent quarterly earnings:
Nov 7, 2024Recent annual earnings:
Mar 7, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Dec 9, 2020Analyst ratings
Recent major analysts updates
Feb 6, 25 Chardan Capital
BuyJan 7, 25 Citigroup
BuyDec 5, 24 HC Wainwright & Co.
BuyNov 11, 24 HC Wainwright & Co.
BuyNov 11, 24 Baird
OutperformNov 8, 24 Chardan Capital
BuyOct 29, 24 Chardan Capital
BuyOct 25, 24 HC Wainwright & Co.
BuyAug 13, 24 JP Morgan
OverweightJun 28, 24 Chardan Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
EyePoint Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for EyePoint Pharmaceuticals?
- Does EyePoint Pharmaceuticals pay dividends?
- What sector is EyePoint Pharmaceuticals in?
- What industry is EyePoint Pharmaceuticals in?
- What country is EyePoint Pharmaceuticals based in?
- When did EyePoint Pharmaceuticals go public?
- Is EyePoint Pharmaceuticals in the S&P 500?
- Is EyePoint Pharmaceuticals in the NASDAQ 100?
- Is EyePoint Pharmaceuticals in the Dow Jones?
- When was EyePoint Pharmaceuticals's last earnings report?
- When does EyePoint Pharmaceuticals report earnings?
- Should I buy EyePoint Pharmaceuticals stock now?
What is the ticker symbol for EyePoint Pharmaceuticals?
The ticker symbol for EyePoint Pharmaceuticals is NASDAQ:EYPT
Does EyePoint Pharmaceuticals pay dividends?
No, EyePoint Pharmaceuticals does not pay dividends
What sector is EyePoint Pharmaceuticals in?
EyePoint Pharmaceuticals is in the Healthcare sector
What industry is EyePoint Pharmaceuticals in?
EyePoint Pharmaceuticals is in the Biotechnology industry
What country is EyePoint Pharmaceuticals based in?
EyePoint Pharmaceuticals is headquartered in United States
When did EyePoint Pharmaceuticals go public?
EyePoint Pharmaceuticals's initial public offering (IPO) was on January 27, 2005
Is EyePoint Pharmaceuticals in the S&P 500?
No, EyePoint Pharmaceuticals is not included in the S&P 500 index
Is EyePoint Pharmaceuticals in the NASDAQ 100?
No, EyePoint Pharmaceuticals is not included in the NASDAQ 100 index
Is EyePoint Pharmaceuticals in the Dow Jones?
No, EyePoint Pharmaceuticals is not included in the Dow Jones index
When was EyePoint Pharmaceuticals's last earnings report?
EyePoint Pharmaceuticals's most recent earnings report was on Nov 7, 2024
When does EyePoint Pharmaceuticals report earnings?
The next expected earnings date for EyePoint Pharmaceuticals is Mar 5, 2025
Should I buy EyePoint Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions